Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis.

Interleukin 17 is a T cell-derived cytokine that induces the release of pro-inflammatory mediators in a wide range of cell types. Recently, a subset of IL-17-producing T helper cells (Th17) distinct from Th1 and Th2 cells has been described, which constitutes a new T cell polarization state. Aberran...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors: Röhn, T, Jennings, G, Hernandez, M, Grest, P, Beck, M, Zou, Y, Kopf, M, Bachmann, M
Format: Journal article
Sprog:English
Udgivet: 2006
_version_ 1826261844335001600
author Röhn, T
Jennings, G
Hernandez, M
Grest, P
Beck, M
Zou, Y
Kopf, M
Bachmann, M
author_facet Röhn, T
Jennings, G
Hernandez, M
Grest, P
Beck, M
Zou, Y
Kopf, M
Bachmann, M
author_sort Röhn, T
collection OXFORD
description Interleukin 17 is a T cell-derived cytokine that induces the release of pro-inflammatory mediators in a wide range of cell types. Recently, a subset of IL-17-producing T helper cells (Th17) distinct from Th1 and Th2 cells has been described, which constitutes a new T cell polarization state. Aberrant Th17 responses and overexpression of IL-17 have been implicated in a number of autoimmune disorders including rheumatoid arthritis and multiple sclerosis. Molecules blocking IL-17 such as IL-17-specific monoclonal antibodies have proved to be effective in ameliorating disease in animal models. Hitherto, active immunization targeting IL-17 is an untried approach. Herein we explore the potential of neutralizing IL-17 by active immunization using virus-like particles conjugated with recombinant IL-17 (IL-17-VLP). Immunization with IL-17-VLP induced high levels of anti-IL-17 antibodies thereby overcoming natural tolerance, even in the absence of added adjuvant. Mice immunized with IL-17-VLP had lower incidence of disease, slower progression to disease and reduced scores of disease severity in both collagen-induced arthritis and experimental autoimmune encephalomyelitis. Active immunization against IL-17 therefore represents a novel therapeutic approach for the treatment of chronic inflammatory diseases.
first_indexed 2024-03-06T19:26:59Z
format Journal article
id oxford-uuid:1c1ad835-cf39-4d9e-838c-4c11a3bea33c
institution University of Oxford
language English
last_indexed 2024-03-06T19:26:59Z
publishDate 2006
record_format dspace
spelling oxford-uuid:1c1ad835-cf39-4d9e-838c-4c11a3bea33c2022-03-26T11:03:52ZVaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:1c1ad835-cf39-4d9e-838c-4c11a3bea33cEnglishSymplectic Elements at Oxford2006Röhn, TJennings, GHernandez, MGrest, PBeck, MZou, YKopf, MBachmann, MInterleukin 17 is a T cell-derived cytokine that induces the release of pro-inflammatory mediators in a wide range of cell types. Recently, a subset of IL-17-producing T helper cells (Th17) distinct from Th1 and Th2 cells has been described, which constitutes a new T cell polarization state. Aberrant Th17 responses and overexpression of IL-17 have been implicated in a number of autoimmune disorders including rheumatoid arthritis and multiple sclerosis. Molecules blocking IL-17 such as IL-17-specific monoclonal antibodies have proved to be effective in ameliorating disease in animal models. Hitherto, active immunization targeting IL-17 is an untried approach. Herein we explore the potential of neutralizing IL-17 by active immunization using virus-like particles conjugated with recombinant IL-17 (IL-17-VLP). Immunization with IL-17-VLP induced high levels of anti-IL-17 antibodies thereby overcoming natural tolerance, even in the absence of added adjuvant. Mice immunized with IL-17-VLP had lower incidence of disease, slower progression to disease and reduced scores of disease severity in both collagen-induced arthritis and experimental autoimmune encephalomyelitis. Active immunization against IL-17 therefore represents a novel therapeutic approach for the treatment of chronic inflammatory diseases.
spellingShingle Röhn, T
Jennings, G
Hernandez, M
Grest, P
Beck, M
Zou, Y
Kopf, M
Bachmann, M
Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis.
title Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis.
title_full Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis.
title_fullStr Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis.
title_full_unstemmed Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis.
title_short Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis.
title_sort vaccination against il 17 suppresses autoimmune arthritis and encephalomyelitis
work_keys_str_mv AT rohnt vaccinationagainstil17suppressesautoimmunearthritisandencephalomyelitis
AT jenningsg vaccinationagainstil17suppressesautoimmunearthritisandencephalomyelitis
AT hernandezm vaccinationagainstil17suppressesautoimmunearthritisandencephalomyelitis
AT grestp vaccinationagainstil17suppressesautoimmunearthritisandencephalomyelitis
AT beckm vaccinationagainstil17suppressesautoimmunearthritisandencephalomyelitis
AT zouy vaccinationagainstil17suppressesautoimmunearthritisandencephalomyelitis
AT kopfm vaccinationagainstil17suppressesautoimmunearthritisandencephalomyelitis
AT bachmannm vaccinationagainstil17suppressesautoimmunearthritisandencephalomyelitis